Jul 1 2018;24(4):416-441
GHK-Cu is easy to find online, but not every product is made for patient use, prescribed by a licensed provider, or prepared through a regulated pharmacy
PREVIEW Wells Fargo & Company Q1 2022 Earnings Conference Call April 14, 2022 Executives in Attendance: John Campbell - Director, IR Charlie Scharf - CEO Mike Santomassimo - CFO Analysts Present: Scott Siefers - Piper Sandler Steven Chubak - Wolfe Research John Pancari - Evercore ISI Ken Usdin - Jefferies John McDonald - Autonomous Research Ebrahim Poonawala - Bank of America Betsy Graseck - Morgan Stanley Matt OConnor - Deutsche Bank Erika Najarian - UBS Charles Peabody - Portales Partner Gerard Cassidy - RBC Capital Market Erika Najarian - UBS Comments from Charlie Scharf - CEO: Now, let me update you on progress weve made on our strategic priorities
What this means for clinical research: Clinical timelines are no longer shaped by execution alone
They are not FDA-approved treatments for disc herniations
People who have previously run GLP-1 based compounds and noticed post-cycle skin changes, either laxity or reduced firmness compared to their target weight look, are strong candidates for adding GHK-Cu to their next Retatrutide cycle